Virtual Q&A: Feb. 3, 10 am, Drug Discovery and Development Programs

 

Join the College of Pharmacy for a Virtual Q&A session on Thursday, February 3 at 10 am about the Drug Discovery and Development programs (Certificate and Master of Science). Students interested in these programs may register for the Zoom link here:
https://bit.ly/REGISTERDDD2022

Learn more:

Watch the video: https://youtu.be/XjER0MAvho8

Certificate: https://www.unthsc.edu/college-of-pharmacy/about-us/certificate-in-drug-discovery-and-development/

Master of Science: https://www.unthsc.edu/college-of-pharmacy/about-us/master-of-science-in-drug-discovery-and-development/

Notification of heavy parking on campus: January 26 and February 2

 

HEAVY PARKING NOTIFICATION:

Please discuss with your supervisor if remote work is an option for you.

HSC will host interprofessional exercises which will bring 200 additional students from other campuses to our campus at these times:

  • Wednesday, Jan. 26, 1 -5 p.m.
  • Wednesday, Feb. 2, 1 -5 p.m.

Please note that (regardless of how congested lots and garages become) parking is not allowed in these areas:

  • Lot 1 (reserved for patient parking only; will receive HSC citation).
  • Lot 7 spaces reserved for Piola Restaurant patrons; will receive HSC citation.

Owners of these parking lots will tow unauthorized vehicles:

  • CVS, northwest corner of Camp Bowie Boulevard and Montgomery Street.
  • McDonalds, southwest corner of Camp Bowie Boulevard and Montgomery Street.
  • Chicotsky’s shopping area, southeast corner of West Seventh and Clifton streets.

The City of Fort Worth will issue citations for those who park on nearby streets labeled “Resident Parking.”

As always, if you cannot find parking, please contact the Parking Office at 817-735-2211. Parking specialists will use their live video cameras to locate a parking spot for you.

Your patience is greatly appreciated. Anyone with questions may contact Parking@unthsc.edu.

Lorena M. Amaral, Ph.D. to present seminar on 1/28/22 at 11:00 AM: “Progesterone and PIBF: new insights into treatment options for preeclampsia”.

 

Lorena M. Amaral, Ph.D.
Assistant Professor, Department of Pharmacology & Toxicology
University of Mississippi Medical Center

“Progesterone and PIBF: new insights into treatment options for preeclampsia”

Preeclampsia affects 5-7% of all pregnancies in the U.S. and despite being a leading cause of maternal death and perinatal morbidity, the mechanisms responsible for the pathogenesis of preeclampsia still are unclear. My research interest is to study the pathophysiology of hypertensive disorders of pregnancy and identify novel therapeutic targets for this maternal syndrome. Over the years, my laboratory has been focused on examining the effects of progesterone on pathophysiology of preeclampsia. Through our collaboration with the Maternal-Fetal Medicine Department in Obstetrics and Gynecology, we have shown that a large percentage of our patient population delivering at the UMMC Wiser hospital are hypertensive and have significantly lower circulating progesterone compared to healthy pregnant women. Therefore, my laboratory is interested in the role of progesterone in hypertensive disorders of pregnancy. Currently we are working on the following projects: 1) To identify the role of progesterone on immunologic mechanisms in response to preeclampsia. 2) To identify the role of Progesterone Induced Blocking Factor (PIBF), either by supplementation or via progesterone in rodent models of preeclampsia.

Friday, January 28, 2022, 11:00AM-12:00PM, EAD-406
University of North Texas Health Science Center
Fort Worth, Texas

Workout of the Day 01/28/2022

 

Perform 4 rounds of:

1 min. Jumping jacks.

1 min. Skiers

– Rest 1-minute –

1 min. Run in place

1 min. Mountain climbers

– Rest 1-minute –

1 min. Skip in place

1 min. Burpees